557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Hydroxychloroquine (HQN) is an experimental treatment for COVID-19. Effects of coadministration of HQN with RDV have not been studied and are relevant given the long half-lif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Arribas, Jose Ramon, Sanyal, Arun J, Soriano, Alex, Chin, Bum Sik, Kalimuddin, Shirin, Schreiber, Stefan, Elboudwarej, Emon, Tian, Yuan, Hyland, Robert H, SenGupta, Devi, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Lübbert, Christoph, Lye, David Chien Boon, Aberg, Judith A, Elorza, Enrique Navas, Tashima, Karen T, McPhail, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776163/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.751
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados